首页 正文

Nebulized surfactant in preterm neonates ≤34 weeks of gestation with respiratory distress syndrome: a pilot study

{{output}}
Respiratory distress syndrome (RDS) is a leading cause of morbidity and mortality in preterm neonates. Aerosolized (nebulized) surfactant offers a non-invasive safe alternative. However, its safety, feasibility, and clinical effectiveness in low-resource setti... ...